SCHEMBL6540371

SCHEMBL6540371

COc1ccccc1CNCC[C@@H]1[C@@H](O)CCN1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 6/20 0.53
▸ ACHE P22303 6/20 0.53
▸ CHRM2 P08172 9/20 0.52
▸ CHRM4 P08173 2/20 0.52
▸ CHRM5 P08912 2/20 0.52
▸ CHRM1 P11229 2/20 0.52
▸ CHRM3 P20309 2/20 0.52
▸ CXCR4 P61073 1/20 0.48
▸ DPP7 Q9UHL4 1/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ SIGMAR1 Q99720 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ GRIN1 Q05586 4/20 0.46
▸ GRIN2A Q12879 4/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ THPO P40225 1/20 0.46
▸ RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6541826 0.90 CXCR4 (0.55) BCHEACHECHRM2CHRM4CHRM5
SCHEMBL23459312 0.83 KMT2A (0.49) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6540368 0.78 TACR1 (0.46) CHRM5CXCR4KMT2ATSHRSIGMAR1
SCHEMBL23459007 0.73 SMN1; SMN2 (0.46) KMT2ASIGMAR1MEN1CYP2D6
SCHEMBL23459009 0.73 SMN1; SMN2 (0.46) KMT2ASIGMAR1MEN1CYP2D6
SCHEMBL3210838 0.71 CHRM2 (0.63) BCHEACHECHRM2CHRM4CHRM5
SCHEMBL6333454 0.71 CXCR4 (0.48) BCHEACHECHRM2CXCR4DPP7
SCHEMBL23023124 0.71 CHRM2 (0.59) BCHEACHECHRM2CHRM4CHRM5
SCHEMBL4918396 0.70 CHRM2 (0.79) BCHEACHECHRM2CHRM4CHRM5
SCHEMBL29997324 0.70 CYP2D6 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6787543-B2 PREPARATION OF TACHYKININ ANTAGONISTS; SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-09-07 — — US disclosed
Send feedback